Gaming stocks: Chinese gaming stocks rally as regulatory official removal boosts confidence- Republic World

[ad_1] Updated January 3rd, 2024 at 10:19 IST China reportedly removed Feng Shixin from a government body responsible for overseeing its press and publications regulator. Representative image of stock market…

Cipla stock tanks 8% after USFDA warning over issues at MP unit

[ad_1] Shares of pharma giant Cipla Ltd plunged as much as 8% to hit an intraday low of ₹1165.10 apiece on BSE after the United States Food and Drug Administration (USFDA)…

Cipla, Bandhan Bank, Dr Reddy’s Labs: Trading strategies for these buzzing stocks

[ad_1] Domestic stock indices extended gains for the second straight session on Wednesday. Weakness in banking and financials weighed, as gains were largely capped.  The BSE Sensex rose 92.47 points,…

Stocks in news: SBI Cards, NBCC, Cipla, Dabur and more

[ad_1] The domestic equity market closed lower on Friday. Sensex fell 188 points to end the session at 65,794 and Nifty lost 33 points to settle at 19,732.        Here’s…

Cipla net soars 43% on growth in India, other key markets

[ad_1] NEW DELHI :Cipla Ltd posted a 43.4% rise in consolidated net profit for the quarter ended September to ₹1,130.91 crore, against ₹788.90 crore in the corresponding quarter of last…

Cipla surges 4% on beating Q2 estimates; profit jumps 43%, revenue up 15%

[ad_1] Cipla Ltd’s stock price surged up to 4 per cent on BSE to an intra-day high of Rs 1,197 apiece on Friday after the company posted better than expected…

Family rift clouds $7 bn sale of Cipla

[ad_1] Differences within the Hamied family, Cipla Ltd’s promoters, over the pricing of the deal and the decision of patriarch Yusuf K. Hamied to sell the drugmaker threaten to derail…

Cipla plans acquisitions to take top spot in South Africa drug market

[ad_1] Cipla is eyeing the number one position in the South African market, which roughly accounts for a little over 10 per cent of its consolidated turnover. During the first…

Cipla shares rise 2% on deal to acquire South Africa’s Actor Pharma

[ad_1] “This development underpins Cipla’s commitment and investment in its over the counter (OTC) business and supports its journey to be a leading healthcare player in South Africa,” Cipla said…